Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Triflusal and Clopidogrel Effect in Secondary Prevention of Stroke Based on the Cytochrome P450 2C19 Genotyping

NCT01174693 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT01174693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01174693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Triflusal and Clopidogrel Effect in Secondary Prevention of Stroke Based on the Cytochrome P450 2C19 Genotyping
Lead sponsor
Gangnam Severance Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
March 31, 2015
Enrollment
795 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction